Hepatoma Research_2020年1期_参考网

Hepatoma Research

2020年1期

浏览往期订阅

目录

Original Article
1. Interim results from ongoing Phase III placebo-controlled, randomized trial of hepcortespenlisimut-L for advanced hepatocellular carcinoma indication
1. First cases of MPV17 related mitochondrial DNA depletion syndrome with compound heterozygous mutations in p.R50Q/p.R50W: a case report